KEROS THERAPEUTICS INC

Ticker: KROS CUSIP: 492327101 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 43,500 Value ($000) $2,526 Avg Close $49.39 Range $40.93 - $59.06
Q2 2024
Shares 22,377 Value ($000) $1,023 Avg Close $53.73 Range $43.30 - $67.30
Q1 2024
Shares 272,971 Value ($000) $18,071 Avg Close $59.30 Range $39.00 - $73.00
Q4 2023
Shares 49,472 Value ($000) $1,967 Avg Close $31.36 Range $27.02 - $41.92
Q2 2023
Shares 62,650 Value ($000) $2,517 Avg Close $43.84 Range $37.03 - $51.16
Q1 2023
Shares 116,520 Value ($000) $4,975 Avg Close $50.51 Range $39.98 - $59.96
Q4 2022
Shares 6,400 Value ($000) $307 Avg Close $46.71 Range $37.40 - $52.78
Q2 2022
Shares 52,934 Value ($000) $1,464 Avg Close $43.88 Range $24.38 - $68.29
Q1 2022
Shares 7,468 Value ($000) $406 Avg Close $51.33 Range $39.75 - $60.42
Q4 2021
Shares 5,727 Value ($000) $335 Avg Close $49.87 Range $36.13 - $63.47
Q3 2021
Shares 49,636 Value ($000) $1,964 Avg Close $35.59 Range $28.50 - $44.87
Q2 2021
Shares 12,055 Value ($000) $512 Avg Close $54.17 Range $41.88 - $71.74
Q1 2021
Shares 5,877 Value ($000) $362 Avg Close $63.36 Range $51.48 - $75.99
Q4 2020
Shares 17,492 Value ($000) $1,234 Avg Close $63.02 Range $34.17 - $88.80